with advanced prostate cancer and to look at the impact on patient's general health, quality of life, life expectancy and complications after PCN ... F New,S Deverill,BK Somani - 《Central European Journal of Urology》 被引量: 0发表: 2018年 A cost-utility analysis of degarelix in the ...
2016-2018.CONCLUSION:QoL is not assessed or published in many phase III lung cancer trials, a setting where QoL value should be highly considered, due to high symptom burden and generally limited life expectancy. Timely inclusion of results in primary publications is worsening in recent years....
Patients with ESRD have extensive and unique palliative care needs, often for years before death. The vast majority of patients, however, dies in acute car... SN Davison - 《Clinical Journal of the American Society of Nephrology Cjasn》 被引量: 64发表: 2012年 Predicting life expectancy in pa...
Search strings are summarized in Additional file1: Table S1, and were constructed not only to find utilities in mNSCLC (using a wide range of NSCLC and mNSCLC terms combined with the HSUV filter adapted from Arber et al. 2015 [30]) but also to identify all relevant disutilities or utility...
[23]. Concerns include but are not limited to increased symptom burden, treatment side effects, and declining life expectancy in those with advanced disease [23]. However, research has begun to show that exercise may be safe and feasible in advanced cancer patients [23]. Therefore, we aim ...